Neuren Pharmaceuticals Limited (NK9)
Market Closed
10 Aug, 12:14
XFRA 
€
14. 30
+0.2
+1.4184%
€
- Market Cap
- P/E Ratio
- Div Yield
1,531 Volume
- Eps
€ 14.1
Previous Close Want to track NK9 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
NK9 closed today higher at €14.3, an increase of 1.4184% from yesterday's close, completing a monthly increase of 28.8288% or €3.2. Over the past 12 months, NK9 stock gained 38.835%.
NK9 is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2026, missed the consensus estimates by -0.0135%. On average, the company has fell short of earnings expectations by -0.0785%, based on the last three reports.
Neuren Pharmaceuticals Limited has completed 3 stock splits, with the recent split occurring on Nov 21, 2017.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on ASX (AUD).
NK9 Chart
Neuren Pharmaceuticals Limited (NK9) FAQ
What is the stock price today?
The current price is €14.30.
On which exchange is it traded?
Neuren Pharmaceuticals Limited is listed on XFRA.
What is its stock symbol?
The ticker symbol is NK9.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Neuren Pharmaceuticals Limited ever had a stock split?
Neuren Pharmaceuticals Limited had 3 splits and the recent split was on Nov 21, 2017.
Neuren Pharmaceuticals Limited Profile
| Biotechnology Industry | Healthcare Sector | - CEO | XFRA Exchange | NZNEUE0001S8 ISIN |
| Germany Country | - Employees | - Last Dividend | 21 Jun 2011 Last Split | - IPO Date |
Contact Information
Address: -
Phone: -
